711
Participants
Start Date
October 31, 2012
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
CK-2017357
CK-2017357 125 mg tablets twice daily
Placebo tablets
Tablets
Riluzole
Tablets
Trinity College, Beaumont Hospital, Dublin
Hospital for Special Surgery, New York
Hôpital La Timone Adulte, Marseille
SUNY Upstate Medical University, Syracuse
Charite Universitätsmedizin, Berlin
University of Rochester, Rochester
University of Pittsburgh, Pittsburgh
Penn State Hershey Neuroscience Clinics, Hershey
Drexel Neurology, Philadelphia
University of Pennsylvania, Philadelphia
The George Washington University, Washington D.C.
Johns Hopkins University, Baltimore
University of Virginia, Charlottesville
West Virginia University Department of Neurology, Morgantown
Wake Forest University, School of Medicine, Winston-Salem
Carolinas Medical Center Department of Neurology, Charlotte
Duke University, Durham
Hospital Carlos III, Madrid
Emory University, School of Medicine, Atlanta
Hannover Medical School, Hanover
Georgia Health Sciences University, Augusta
Mayo Clinic Florida Department of Neurology, Jacksonville
Hôpital Bretonneau, Tours
Vanderbilt University Medical Center, Nashville
Ohio State University Department of Neurology, Columbus
Indiana University Department of Neurology, Indianapolis
University of Michigan, Ann Arbor
Henry Ford Hospital, Detroit
St Mary's Healthcare, Grand Rapids
University of Iowa Hospitals and Clinics, Iowa City
Medical College of Wisconsin, Milwaukee
Hennepin County Medical Center - Berman Center for Research, Minneapolis
Saint Louis University, St Louis
Washington University, St Louis
University of Kansas, Kansas City
Neurology Associates, Lincoln
Texas Neurology, Dallas
Baylor College of Medicine, Houston
UTHSCSA Department of Neurology, San Antonio
Barrow Neurology, Phoenix
University of Ulm, Ulm
University of California, San Diego, La Jolla
Coordinated Clinical Research, San Diego
UC Irvine ALS & Neuromuscular Center, Orange
California Pacific Medical Center Forbes Norris MDA/ALS Research Center, San Francisco
Providence ALS Center, Portland
Oregon Health & Science University, Portland
Hospital for Special Care, New Britain
Massachusetts General Hospital, Boston
University of Massachusetts Medical School, Worcester
Dartmouth Hitchcock Medical Center, Lebanon
Heritage Medical Research, Calgary
University of Alberta Hospital, Edmonton
QE II Health Sciences Centre, Halifax
University of British Columbia, Vancouver
Stan Cassidy Centre for Rehabilitation, Fredericton
McMaster University Medical Centre, Hamilton
Queen's University : Kingston General, Kingston
London Health Sciences, London
Univ. of Toronto - Sunnybrook Health Sciences Centre, Toronto
Hôpital Notre Dame (CHUM) Centre Hospitalier de l'Universite de Montreal, Montreal
Montreal Neurological Institute, Montreal
CHU de Quebec: Hopital l'Enfant-Jesus, Québec
CHRU de Lille - Hôpital Roger Salengro, Lille
CHU de Limoges - Hôpital Dupuytren, Limoges
CHU Montepellier, Montpellier
Hôpital Archet 1, Nice
Hôpital de la Salpêtrière, Paris
Universitair Medisch Centrum Utrecht, Utrecht
Barts and the London MND & the Centre Royal London Hospital, Whitechapel
Walton Centre for Neurology and Neurosurgery, Liverpool
Kings College Hospital NHS Foundation Trust, London
John Radcliffe Hospital, Oxford
Plymouth Hospitals NHS Trust, Plymouth
Sheffield Institute for Translational Neuroscience, Sheffield
Lead Sponsor
Cytokinetics
INDUSTRY